Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of cancer cell knockdown of EphB4 in a Moc2 tumor model

ABSTRACT: Effect of cancer cell knockdown of EphB4 in a Moc2 tumor model

PROVIDER: PRJNA828565 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18838066_1.fastq.gz	Fastqsanger.gz
	SRR18838066_2.fastq.gz	Fastqsanger.gz
	SRR18838067_1.fastq.gz	Fastqsanger.gz
	SRR18838067_2.fastq.gz	Fastqsanger.gz
	SRR18838068_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 10

Similar Datasets

Effect of METTL3 knockdown on MCF10 breast cancer progression model

Project description:Effect of METTL3 knockdown on MCF10 breast cancer progression model

| PRJNA993659 | ENA

Effect of cancer cell knockdown of EphB4 in a Moc2 tumor model

Project description:To investigate the functional significance of EphB4, we generated cancer cell-specific knockdown of EphB4 in a head and neck cancer cell line, Moc2, using shRNA approach. These cells along with the controls were orthotopically implanted in a C57BL/6 murine model and tumors for harvested for RNA-seq analysis

2022-04-28 | GSE201148 | GEO

CD73 knockdown effect in pancreatic cancer cell lines

Project description:CD73 knockdown effect in pancreatic cancer cell lines

| PRJNA480855 | ENA

Effect of KLK5 knockdown and PRSS3 knockdown in PC9 lung cancer cells

Project description:Effect of KLK5 knockdown and PRSS3 knockdown in PC9 lung cancer cells

| PRJNA448949 | ENA

Effect of KLK5 knockdown in PC9 lung cancer cells

Project description:Effect of KLK5 knockdown in PC9 lung cancer cells

| PRJNA448952 | ENA

Effect of PRSS3 knockdown in PC9 lung cancer cells

Project description:Effect of PRSS3 knockdown in PC9 lung cancer cells

| PRJNA448953 | ENA

The effect of MFNG knockdown on gene expression profile of xenograft tumor derived from MDA-MB231 cells

Project description:Mfng, a modulator of Notch signaling, is highly expressed in human claudin-low breast cancer (CLBC). To determine Mfng’s roles in CLBC pathogenesis,we knocked down Mfng in a CLBC cell line MDA-MB231, and found that Mfng knockdown altered Notch activation, decreased tumor sphere formation in vitro, and reduced tumor growth in xenograft model. To identify the potential downstream targets of Mfng during CLBC tumorigenesis, we compared the gene expression profiles between xenografts tumor derived from of MDA-MB231 cells carrying Mfng shRNA and the control vector. Mfng, a modulator of Notch signaling, is highly expressed in human claudin-low breast cancer (CLBC). To determine Mfng’s roles in CLBC pathogenesis,we knocked down Mfng in a CLBC cell line MDA-MB231, and found that Mfng knockdown caused alteration in Notch activation, associated with decreased tumor sphere formation in vitro, as well as reduced tumor growth in xenograft model. We intend to compare gene expression profiles between xenografts of MDA-MB231 cells carrying Mfng shRNA and the control vector. This project seeks to identify potential downstream targets of Mfng in CLBC. MDA-MB231 cells were transfected with shRNA against MFNG. Stable cell clones with knockdown of MFNG or corresponding control were selected and injected orthotopically into SCID mice. Total RNA was then extracted from the xenograph tumors for microarray analysis.

2015-05-01 | E-GEOD-62481 | biostudies-arrayexpress

Effect of Ifnar1 Knockdown in a mouse model of Cerebral Interferonopathy

Project description:Effect of Ifnar1 Knockdown in a mouse model of Cerebral Interferonopathy

| PRJNA967033 | ENA

The effect of attenuated Salmonella typhimurium on the tumor epithelium in mouse colorectal cancer model

Project description:The effect of attenuated Salmonella typhimurium on the tumor epithelium in mouse colorectal cancer model

| PRJNA560971 | ENA

Knockdown of the Prolactin Receptor Inhibits Recruitment of Tregs and their Promotion of EMT in a Syngeneic Breast Cancer Model

Project description:The clinical relevance and prognostic significance of tumor-infiltrating Tregs in different types of cancers makes them appealing therapeutic targets. However, while effective at inhibiting cancer progression, immunotherapeutics targeting Treg function have adverse effects in a substantial proportion of patients, ranging from mild inflammatory disorders to frank autoimmune disease. Here, we report that systemic knockdown of the long form of the prolactin receptor (LFPRLR) inhibits recruitment of Tregs to primary tumors and, importantly, metastasis-promoting activities of tumor Tregs, with no change in the production of TGFβ or IL-10 by tumor Tregs or the ability of peripheral Tregs to suppress anti-CD3/CD28-stimulated effector cell proliferation. Knockdown of the LFPRLR was accomplished using a derivatized DNA splice-modulating oligomer and outcome was assessed in the highly-metastatic, syngeneic, orthotopic 4T1-Balb/c immune-competent breast cancer model. We conclude that knockdown of the LFPRLR produces a more functionally-specific anti-cancer effect in Tregs, suggesting promise as a future therapeutic approach.

2019-02-28 | GSE111329 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data